Myeloid-derived suppressor cells (MDSCs) are expanded in tumor microenvironments,
including that of Epstein–Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) …

Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV)
infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The …

Non‐keratinizing nasopharyngeal carcinoma (NPC) is closely associated with Epstein–Barr
virus (EBV) infection. The EBV‐encoded latent membrane protein 1 (LMP1) is believed to …

It has been recently reported that a side population of cells in nasopharyngeal carcinoma
(NPC) displayed characteristics of stem-like cancer cells. However, the molecular …

Our goal in this work was to illustrate the Epstein-Barr virus (EBV)-modulated global
biochemical profile and provide a novel metabolism-related target to improve the therapeutic …

EBV-encoded LMPs are consistently detected in nasopharyngeal carcinoma (NPC). Recent
evidence suggests potential roles of LMP1 and LMP2A in Epithelial-to-mesenchymal …

Several reports have demonstrated that Epstein-Barr virus (EBV) encoded latent membrane
protein 1 (LMP1), which is transferred by extracellular vesicles (EVs) or exosomes, can …

Abstract Latent membrane protein 1 (LMP1) is a principal viral oncoprotein in Epstein-Barr
virus (EBV)-associated malignancies, including nasopharyngeal carcinoma (NPC), which …

Radioresistance has been one of the impediments to effective nasopharyngeal carcinoma
(NPC) therapy in clinical settings. Epstein‐Barr virus (EBV) encoded latent membrane …

Emerging evidence confirms that cancer stem cells (CSCs) are responsible for the
chemoradioresistance of malignancies. EBV-encoded latent membrane protein 1 (LMP1) is …